Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion type Assertion NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_head.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion description "[The receptor tyrosine kinase ErbB2 (HER-2/neu) is overexpressed in up to 30% of breast cancers and is associated with poor prognosis and an increased likelihood of metastasis especially in node-positive tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_provenance.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion evidence source_evidence_literature NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_provenance.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion SIO_000772 16048908 NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_provenance.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion wasDerivedFrom befree-2016 NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_provenance.
- NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_assertion wasGeneratedBy ECO_0000203 NP505987.RAQkrsO284BvlDcWWgHfZkwG31yATRopl44H9sMPQItSo130_provenance.